Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Plasma cell 2Other neoplasm 1Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Immunoglobulin Light-chain Amyloidosis 2Amyloidosis 2Amyloidosis, Familial 1AA amyloidosis 1

Interventions

Dexamethasone 293Lenalidomide 162Bortezomib 160Cyclophosphamide 121Calcium Dobesilate 118Melphalan 116fludarabine phosphate 75carfilzomib 62pomalidomide 57Whole-Body Irradiation 57Mycophenolic Acid 56Granulocyte Colony-Stimulating Factor 55Peripheral Blood Stem Cell Transplantation 54Filgrastim 54fludarabine 50daratumumab 50Tacrolimus 45Busulfan 45ixazomib 42Thalidomide 37Cyclosporine 32Stem Cell Transplantation 29dexamethasone acetate 28Antilymphocyte Serum 26dexamethasone 21-phosphate 23plerixafor 21elotuzumab 20auricularum 20belantamab mafodotin 19Prednisone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Doxycycline × Plasma cell × Clear all
NCT02207556 2021-07-09

DUAL

Medical College of Wisconsin

Phase 2 Completed
32 enrolled 15 charts
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT01677286 2017-08-01

Safety and Effect of Doxycycline in Patients With Amyloidosis

Boston University

Phase 2 Completed
25 enrolled 13 charts
Plasma cell

AA amyloidosis, Immunoglobulin Light-chain Amyloidosis, Amyloidosis, Amyloidosis, Familial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡